News & Events

HTG Molecular Diagnostics to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on Thursday, March 7

TUCSON, Ariz. , Feb. 21, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the quarter and year ended December 31, 2018 after the market close

full press release

Posted on:

Return To List

Page last updated